The effect of de-escalation of P2Y12 receptor inhibitor therapy after acute myocardial infarction in patients undergoing percutaneous coronary intervention: A nationwide cohort study

To examine the effect of de-escalation of P2Y12 inhibitor in dual antiplatelet therapy (DAPT) on major adverse cardiovascular events (MACE) and bleeding complications after acute myocardial infarction (AMI) in Taiwanese patients undergoing percutaneous coronary intervention (PCI). Patients who had r...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PloS one 2021-01, Vol.16 (1), p.e0246029-e0246029
Hauptverfasser:	Yeh, Jong-Shiuan, Hsu, Chien-Yi, Huang, Chun-Yao, Chen, Wan-Ting, Hsieh, Yi-Chen, Chien, Li-Nien
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute coronary syndromes Angioplasty Angiotensin Angiotensin II Angiotensin-converting enzyme inhibitors Anticoagulants Antiplatelet therapy Aspirin Beneficiaries Bleeding Cardiology Clopidogrel Cohort analysis Computer centers Coronary artery Coronary vessels Enzyme inhibitors FDA approval Genotypes Health insurance Health risks Heart attacks Heart surgery Heparin HMG-CoA reductase inhibitors Homogeneity Hospitals Hydroxymethylglutaryl-CoA reductase Internal medicine Medicine Medicine and Health Sciences Myocardial infarction Patients People and Places Peptidyl-dipeptidase A Platelets R&D Receptors Reductases Research & development Social Sciences
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!